In the course of a recently concluded trial over a medical imaging dye called Omniscan, witnesses claimed that manufacturer GE Healthcare actively tried to suppress evidence that the dye could be dangerous, ProPublica reports.
A jury in Cleveland recently awarded $4.5 million to the plaintiff – a 61-year-old man diagnosed with a disease called nephrogenic systemic fibrosis in 2010 — and $500,000 to his wife. Prior to that trial, GE had ...
continue reading...
A Cleveland jury ruled that GE Healthcare failed to adequately warn of health risks connected with its medical imaging dye, marketed under the name Omniscan, which is injected into patients to sharpen MRI scans.
The jury awarded $4.5 million to the plaintiff – a 61-year-old man diagnosed with a disease called nephrogenic systemic fibrosis in 2010 — and $500,000 to his wife, ProPublica reports.
Nephrogenic systemic fibrosis is a rare but debilitating ...
continue reading...
